Pharmacokinetic and dose-finding study of osimertinib in patients with impaired renal function and low body weight.
Fujiwara Y, Makihara R, Hase T, Hashimoto N, Naito T, Tsubata Y, Okuno T, Takahashi T, Kobayashi H, Shinno Y, Zenke Y, Ikeda T, Hosomi Y, Watanabe K, Kitazono S, Sakiyama N, Makino Y, Yamamoto N.
Fujiwara Y, et al. Among authors: yamamoto n.
Cancer Sci. 2023 May;114(5):2087-2097. doi: 10.1111/cas.15736. Epub 2023 Feb 14.
Cancer Sci. 2023.
PMID: 36704833
Free PMC article.